Back
Kura Oncology, Inc. 10K Form
Sell
37
KURA
Kura Oncology, Inc.
Last Price:
$9.85
Seasonality Move:
14.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive KURA News And Ratings
See the #1 stock for the next 7 days that we like better than KURA
KURA Financial Statistics
Sales & Book Value
| Annual Sales: | $53.9M |
|---|---|
| Cash Flow: | $-83.2M |
| Price / Cash Flow: | 10.71 |
| Annual Sales: | $2.79 |
| Price / Book: | 3.65 |
Profitability
| EPS (TTM): | -2.47800 |
|---|---|
| Net Income (TTM): | $-216.9M |
| Gross Margin: | $53M |
| Return on Equity: | -61.97% |
| Return on Assets: | -30.16% |
Kura Oncology, Inc. Earnings Forecast
Key Kura Oncology, Inc. Financial Ratios
-
The Gross Profit Margin over the past 11 years for KURA is 98.43%.
-
The Selling, General & Administrative Expenses for KURA have been equal to 143.11% of Gross Profit Margin.
-
The Research & Development expenses have been 315.44% of Revenue.
-
The Net Earning history of KURA is -322.89% of Total Revenues.
-
Per Share Earnings over the last 11 years have been positive in 3 years.
Kura Oncology, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | KURA |
| CUSIP: | 50127T |
| Website: | kuraoncology.com |
Debt
| Debt-to-Equity Ratio: | 0.08 |
|---|---|
| Current Ratio: | 5.12 |
| Quick Ratio: | 4.53 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
KURA Technical Analysis vs Fundamental Analysis
Sell
37
Kura Oncology, Inc. (KURA)
is a Sell
Is Kura Oncology, Inc. a Buy or a Sell?
-
Kura Oncology, Inc. stock is rated a SellThe current Kura Oncology, Inc. [KURA] share price is $10.18. The Score for KURA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.